GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elekta AB (OSTO:EKTA B) » Definitions » EPS (Diluted)

Elekta AB (OSTO:EKTA B) EPS (Diluted) : kr3.75 (TTM As of Jan. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Elekta AB EPS (Diluted)?

Elekta AB's Earnings per Share (Diluted) for the three months ended in Jan. 2024 was kr0.80. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was kr3.75.

Elekta AB's EPS (Basic) for the three months ended in Jan. 2024 was kr0.80. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2024 was kr3.75.

Elekta AB's EPS without NRI for the three months ended in Jan. 2024 was kr0.88. Its EPS without NRI for the trailing twelve months (TTM) ended in Jan. 2024 was kr3.90.

During the past 12 months, Elekta AB's average EPS without NRIGrowth Rate was 46.60% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -4.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was -5.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 2.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Elekta AB's highest 3-Year average EPS without NRI Growth Rate was 35.00% per year. The lowest was -24.30% per year. And the median was 17.00% per year.


Elekta AB EPS (Diluted) Historical Data

The historical data trend for Elekta AB's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elekta AB EPS (Diluted) Chart

Elekta AB Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.14 2.84 3.28 3.02 2.47

Elekta AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 1.43 0.62 0.90 0.80

Competitive Comparison of Elekta AB's EPS (Diluted)

For the Medical Instruments & Supplies subindustry, Elekta AB's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elekta AB's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elekta AB's PE Ratio distribution charts can be found below:

* The bar in red indicates where Elekta AB's PE Ratio falls into.



Elekta AB EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Elekta AB's Diluted EPS for the fiscal year that ended in Apr. 2023 is calculated as

Diluted EPS (A: Apr. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(943-0)/382.367
=2.47

Elekta AB's Diluted EPS for the quarter that ended in Jan. 2024 is calculated as

Diluted EPS (Q: Jan. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(305-0)/382.000
=0.80

EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr3.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elekta AB  (OSTO:EKTA B) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Elekta AB EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Elekta AB's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Elekta AB (OSTO:EKTA B) Business Description

Address
Kungstensgatan 18, Box 7593, Stockholm, SWE, SE-103 93
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company's installed base of more than 5,000 linear accelerators, GammaKnife and Unity platforms, and software is used in more than 6,000 hospitals globally. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and Asia-Pacific contributing the remainder.

Elekta AB (OSTO:EKTA B) Headlines

No Headlines